Immunology Program
The Michael Glickman Lab
Research
Michael S. Glickman, MD
We are broadly interested in the biology of mycobacteria, which include the major human pathogen M. tuberculosis, the nonpathogenic model organism M. smegmatis, and the cancer biotherapeutic agent BCG.
Research Projects
Featured News
At Work: Infectious Diseases Specialist Michael Glickman
Physician-scientist Michael Glickman cares for cancer patients who have infections. In his laboratory, he aims to understand how infections develop.
MSK Scientists Solve One of TB’s Deadliest Tricks
Scientists at Memorial Sloan Kettering have pieced together the biochemical mechanism by which the tuberculosis bacterium sneaks past our immune defenses.
The ABCs of BCG: Oldest Approved Immunotherapy Gets New Explanation
BCG has been used to treat bladder cancer for more than 30 years. Scientists are still learning how it works.
People
Michael S. Glickman, MD
- Physician-scientist Michael Glickman investigates the physiology and pathogenic mechanisms of mycobacteria, including the use of mycobacteria as bacterial cancer therapies.
- MD, Columbia University College of Physicians and Surgeons
- glickmam@mskcc.org
- Email Address
- 646-888-2368
- Office Phone
- View physician profile
- Physician profile
Members
Member
Senior Research Scientist
Senior Research Scientist
Assistant Attending Physician
Graduate Student
Assistant Lab Member, EIO Cell Bank director
Lab Manager
Postdoctoral Research Associate
Graduate Student
Graduate Student
Research Scholar
Administrative Assistant
Graduate Student
Research Fellow
Graduate Student
Research Scholar
Graduate Student
Research Technician
Graduate Student
Senior Research Technician
Graduate Student
Research Fellow
Research Technician
Research Fellow
Fellow
Postdoctoral Fellow
Technician
Research Technician
Research Associate
ID fellow
Postdoctoral Fellow
Fellow
Research Fellow
